Bill leads the firm’s growth capital investing activities.
VIEW FULL BIO
D. Kyle Wilson
Kyle leads the firm’s M&A advisory activities and has 25 years of investment banking experience.
VIEW FULL BIO
Tim has over 25 years of combined private equity, investment banking and financial advisory experience.
Lars has executed over 100 transactions in a broad range of industries.
Robert WickeOperating Partner
Robert helps lead the technical due diligence of the firm’s capital investing activities.
Anup helps lead the firm’s capital investing activities focused on companies within the molecular biology and software segments.
Holly AtallahDirector of Finance & Operations
Holly has two decades of investment banking, hedge fund investing and corporate development experience.
Austin DukeManaging Director
Austin leads and supports BroadOak's venture capital and early-stage investments.
Michael CaspaniManaging Director
Michael helps lead evaluation, execution, and portfolio management efforts for the firm’s debt and equity investments.
Matt McFarlandManaging Director
Matt leads the firm's pharma services M&A advisory practice and has over 15 years of investment banking experience.
Daniel FriedmanVice President
Daniel specializes in portfolio management and investment execution as part of BroadOak’s growth capital investing team.
Pete CorishVice President of BD, Europe
Pete helps expand access to BroadOak’s expertise, capabilities and services in Europe.
Sean ReuschVice President
Sean is focused on building and expanding BroadOak's growth capital investing activities.
Kathleen provides M&A transaction support, including modeling, materials and process coordination.
Henry specializes in portfolio management and investment execution as part of BroadOak’s growth capital investing team.
Our team is focused on helping life sciences companies realize their full potential.
Now that you've gotten to know us, reach out. We'd like to hear from you.